Prosecution Insights
Last updated: July 17, 2026
Application No. 18/847,268

AGENT FOR ORAL DISEASES

Non-Final OA
Filed
Sep 16, 2024
Priority
Mar 14, 2022 — nonprovisional of PCTJP2022011206
Examiner
ALLEY, GENEVIEVE S
Art Unit
Tech Center
Assignee
Mirailab Bioscience Inc.
OA Round
1 (Non-Final)
60%
Grant Probability
Moderate
1-2
OA Rounds
1y 0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 60% of resolved cases
60%
Career Allowance Rate
439 granted / 727 resolved
At TC average
Strong +48% interview lift
Without
With
+48.5%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
35 currently pending
Career history
771
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
66.7%
+26.7% vs TC avg
§102
6.8%
-33.2% vs TC avg
§112
2.6%
-37.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 727 resolved cases

Prosecution Timeline

Sep 16, 2024
Application Filed
Jun 05, 2026
Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678504
STABLE TRANSDERMAL AMPHETAMINE COMPOSITIONS AND METHODS OF MANUFACTURE
4y 1m to grant Granted Jul 14, 2026
Patent 12677835
STABLE CHLORINATED ALKALINE PRODUCTS
2y 4m to grant Granted Jul 14, 2026
Patent 12678404
DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS
1y 10m to grant Granted Jul 14, 2026
Patent 12674160
STABILIZATION OF RNA FOR EXOGENOUS RNAi AGRICULTURAL APPLICATIONS AND FORMULATIONS
3y 9m to grant Granted Jul 07, 2026
Patent 12668649
MONOGLYCEROL ACRYLATE BASED POLYMER AND USES THEREOF
2y 6m to grant Granted Jun 30, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
60%
Grant Probability
99%
With Interview (+48.5%)
2y 11m (~1y 0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 727 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month